KOR
ENG
Company
Greeting
About Us
Overview
Mission & Vision
History
News
Business
Major Business
Product
All-products
Prescription Drugs
Over-the-Counter Drugs
In Vitro Diagnostic Medical Devices
Life Science Products
Medical Devices
Healthcare Products
Partnering
Introduction
Product Licensing
Contract Manufacturing & QC
R&D
Introduction
Pipeline
Sustainability
Overview
Environment
Social
Governance
Governance structure
Ethical Management
Investor
Financial Information
지금 무엇을 찾으시나요?
추천검색어
Prescription Drugs
Over-the-Conunter Drugs
In Vitro Diagnostic Medical Devices
Life Science Products
Medical Devices
Healthcare Products
한독은 인류의 건강과
삶의 질을 위해 노력합니다.
한독과 함께 변화하는 삶
일상건강에서 만나보세요
Company
Greeting
About Us
Overview
Mission & Vision
History
News
Business
Major Business
Product
All-products
Prescription Drugs
Over-the-Counter Drugs
In Vitro Diagnostic Medical Devices
Life Science Products
Medical Devices
Healthcare Products
Partnering
Introduction
Product Licensing
Contract Manufacturing & QC
R&D
Introduction
Pipeline
Sustainability
Overview
Environment
Social
Governance
Governance structure
Ethical Management
Investor
Financial Information
KR
EN
Company
Greeting
About Us
Overview
Mission & Vision
History
News
Business
Major Business
Product
All-products
Prescription Drugs
Over-the-Counter Drugs
In Vitro Diagnostic Medical Devices
Life Science Products
Medical Devices
Healthcare Products
Partnering
Introduction
Product Licensing
Contract Manufacturing & QC
R&D
Introduction
Pipeline
Sustainability
Overview
Environment
Social
Governance
Governance structure
Ethical Management
Investor
Financial Information
궁금한 부분이 있으신가요?
CONTACT
한독과 함께 변화하는 삶
일상건강
Handok’s Collaborator, Compass Therapeutics, Announces Positive Topline Results from Phase 2/3 of Tovecimig (HDB001A)
Handok Affiliate Rezolute's Congenital Hyperinsulinism Treatment RZ358 Designated as a Breakthrough Therapy by the FDA
Handok Begins Domestic Sales of Hyperlipidemia Treatment Lipidil from Korea Abbott
Handok Affiliate Rezolute's RZ358 Designated as an Orphan Drug by the FDA for the Treatment of Hypoglycemia Due to Tumor-Induced Hyperinsulinism
Handok Hosts 70th Anniversary R&D Symposium on Open Innovation
Handok's Affiliate Rezolute Advances Development of Congenital Hyperinsulinism Treatment (RZ358), Confirming Safety and Proceeding with Phase 3 Trials in the U.S. Without Age Restrictions
Handok's Non-Small Cell Lung Cancer Drug Development Project Selected for Ministry of Trade, Industry and Energy's Global Industry Technology Cooperation Center Program
프레스룸
총
1085
개의 소식들이 있습니다
제56회 '한독학술대상' 충북대학교 약학대학 홍진태 교수 선정
2025.10.22
한독, 함께 배우고 실천하는 ‘당당발걸음 캠페인-혈당관리 원데이 클래스’ 참가자 모집
2025.09.30
한독, 2025년 하반기 신입 직원 공개채용 시작
2025.09.29
[헬스조선] 한 사람이 ‘케토톱’ 1200장을? 리셀러까지 등장했던 사연 [우리 약史]
2025.09.26
한독, 추석 맞이 의료기기 바로잰 기획전 진행
2025.09.22
제11차 일차의료학술상 수상자로 서울봄연합의원 이충형 원장 선정
2025.09.19
약물침투력 높인 쿨 파스, ‘케토톱 액티브 플라스타’ 출시
2025.09.18
강원대학교병원 남우동 원장, 제22회 한독학술경영대상 수상
2025.09.17
한독, 연속혈당측정기 ‘바로잰Fit 전문가용’ 출시
2025.09.09
PREV
1
2
3
4
5
6
7
8
9
10
NEXT